Keyword: Merck

A new screening system confirmed that an emerging class of cancer drugs called IAP antagonists have immune-boosting powers.

The agreement gives Merck control of a drug designed to reduce liver fat content by selectively activating FGFR1c.

Gilead swipes Roche pharma chief for CEO post; Merck promotes oncology, vaccine executives; and Gritstone names new antibody therapeutics chief.

Roche teamed up with immuno-oncology competitor Merck to develop a pan-cancer diagnostic for its Keytruda therapy in mismatch repair deficiency.

Scientists have early evidence that Amgen's oncolytic virus plus PD-1 and MEK inhibitors could be effective in treating melanoma.

Germany's Merck is poised to expand its R&D facilities in China next year.

The FDA granted Bayer and Merck breakthrough device status for AI-based software that spots a rare form of pulmonary hypertension in CT scans.

Elliot Ehrich, M.D., who capped an 18-year career at Alkermes in January, has joined Expansion Therapeutics as its chief medical officer.

Combining a RIP1 inhibitor with Merck's hit checkpoint inhibitor Keytruda holds promise in treating pancreatic cancer, GSK says.